FOXM1 and carcinoma: The oncogenic splice isoforms FOXM1B and/or FOXM1C are over-expressed in all carcinomas examined to date [4], but not in quiescent tissues, suggesting FOXM1 may represent a therapeutic target in many human solid tumor types.